ClinicalTrials.gov record
Completed Phase 3 Interventional

Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma

ClinicalTrials.gov ID: NCT05411198

Public ClinicalTrials.gov record NCT05411198. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 5:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of Ab Externo Implantation of Glaucoma Gel Stent

Study identification

NCT ID
NCT05411198
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
74 participants

Conditions and interventions

Interventions

  • XEN45 (Glaucoma Gel Stent) Device

Device

Eligibility (public fields only)

Age range
45 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 21, 2022
Primary completion
Feb 3, 2026
Completion
Feb 3, 2026
Last update posted
Feb 26, 2026

2022 – 2026

United States locations

U.S. sites
23
U.S. states
15
U.S. cities
22
Facility City State ZIP Site status
Vold Vision /ID# 245285 Fayetteville Arkansas 72704
UCLA Doheny Eye Center /ID# 227587 Pasadena California 91105
Ventura Ophthalmology /ID# 227585 Ventura California 93003
East Coast Institute for Research /ID# 255508 Jacksonville Florida 32256-9680
Center for Sight - Sarasota /ID# 227577 Sarasota Florida 34239
New Vision Eye Center /ID# 261053 Vero Beach Florida 32960-6551
Georgia Eye Partners /ID# 245203 Atlanta Georgia 30342
Stiles Eyecare Excellence /ID# 227576 Overland Park Kansas 66213
The Johns Hopkins Wilmer Eye Institute - Bethesda /ID# 245355 Bethesda Maryland 20817
Vance Thompson Vision /ID# 261125 Alexandria Minnesota 56308-3408
Washington University-School of Medicine /ID# 245452 St Louis Missouri 63110
NYU Langone Medical Center /ID# 227583 New York New York 10016-6402
Fichte Endl & Elmer Eyecare /ID# 245165 Niagara Falls New York 14304
Oklahoma Eye Surgeons /ID# 246840 Oklahoma City Oklahoma 73112
Ophthalmic Partners, PC /ID# 245367 Bala-Cynwyd Pennsylvania 19004
Kremer Eye Center - King of Prussia /ID# 245573 King of Prussia Pennsylvania 19406
Vance Thompson Vision /ID# 260892 Sioux Falls South Dakota 57108
Glaucoma Associates of Texas /ID# 227580 Dallas Texas 75231
University of Texas Southwestern Medical Center /ID# 246848 Dallas Texas 75390-7208
El Paso Eye Surgeons, P.A. /ID# 227575 El Paso Texas 79902
Eye associates /ID# 227572 San Antonio Texas 78229
University of Utah /ID# 245324 Salt Lake City Utah 84112-5500
Northern Virginia Ophthalmology Associates -Falls Church /ID# 246925 Falls Church Virginia 22042-3013

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05411198, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 26, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05411198 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →